Premium
Letter: self‐pay behaviour patients with chronic hepatitis C who required direct acting anti‐viral urgently in a real‐world setting
Author(s) -
Chen T.M.,
Li Y.C.,
Huang P.T.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13536
Subject(s) - daclatasvir , medicine , sofosbuvir , ribavirin , ledipasvir , hepatitis c , hepatitis c virus , pegylated interferon , virology , gastroenterology , virus